MediciNova Total Operating Expenses from 2010 to 2024
| MNOV Stock | USD 1.31 0.07 5.07% |
Total Operating Expenses | First Reported 2004-03-31 | Previous Quarter 2.1 B | Current Value 2.5 M | Quarterly Volatility 239.5 M |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova main balance sheet or income statement drivers, such as Other Operating Expenses of 14.5 M, Research Development of 7.9 M or Total Operating Expenses of 14.4 M, as well as many exotic indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Total Operating Expenses |
Latest MediciNova's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of MediciNova over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. MediciNova's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
MediciNova Total Operating Expenses Regression Statistics
| Arithmetic Mean | 11,989,914 | |
| Geometric Mean | 11,051,553 | |
| Coefficient Of Variation | 30.03 | |
| Mean Deviation | 2,708,689 | |
| Median | 13,027,093 | |
| Standard Deviation | 3,600,133 | |
| Sample Variance | 13T | |
| Range | 14.1M | |
| R-Value | 0.52 | |
| Mean Square Error | 10.2T | |
| R-Squared | 0.27 | |
| Significance | 0.05 | |
| Slope | 417,505 | |
| Total Sum of Squares | 181.5T |
MediciNova Total Operating Expenses History
About MediciNova Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MediciNova income statement, its balance sheet, and the statement of cash flows. MediciNova investors use historical funamental indicators, such as MediciNova's Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although MediciNova investors may use each financial statement separately, they are all related. The changes in MediciNova's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MediciNova's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MediciNova Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 10.9 M | 14.4 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MediciNova in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MediciNova's short interest history, or implied volatility extrapolated from MediciNova options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of MediciNova Correlation against competitors. For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for MediciNova Stock analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is MediciNova's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MediciNova. If investors know MediciNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MediciNova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share 0.02 | Return On Assets (0.09) | Return On Equity (0.13) |
The market value of MediciNova is measured differently than its book value, which is the value of MediciNova that is recorded on the company's balance sheet. Investors also form their own opinion of MediciNova's value that differs from its market value or its book value, called intrinsic value, which is MediciNova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MediciNova's market value can be influenced by many factors that don't directly affect MediciNova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MediciNova's value and its price as these two are different measures arrived at by different means. Investors typically determine if MediciNova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MediciNova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.